A novel multi-cancer early detection test shows promise in initial clinical trials. Nima Nabavizadeh, M.D., says, “It was clear to me, as we were running the study, that we were picking up some novel cancers at an early stage that we previously had no means of detecting … These are largely cancers that we're normally, outside of these blood tests, just waiting to find them, either incidentally or because somebody has symptoms associated with them."

Phil and Penny Knight’s recent $2 billion donation to the Knight Cancer Institute is mentioned in a Forbes article highlighting major donations to HBCUs, noting it as the largest single pledge to a university ever.

The New York Times reports on considerations for use of melatonin, including research pointing to its potential risks for heart health. Andrew McHill, Ph.D., notes taking melatonin can help you adjust to a new time zone or shift your sleep schedule but is not an effective insomnia fix.

The Times of India reports that researchers at AIIMS Bhubaneswar are investigating whether the consumption of foods made from the cycad plant—which contain the suspected neurotoxin BMAA — could be linked to neurological disorders such as Parkinson’s disease and dementia in parts of Odisha. Valerie Palmer, instructor emeritus, and Peter Spencer, Ph.D., have assisted researchers, conducting field visits to the region.

KPTV-TV reports that recreational use of nitrous oxide — often sold in whipped-cream style canisters — is increasingly linked with severe nerve and spinal damage, including paralysis. Courtney Temple, M.D., says the Oregon Poison Center is seeing more such cases. She says, “Even with the correct treatments, sometimes patients have very, very long recovery processes and they may still be incomplete.”

OHSU researchers review new technologies, such as organoids and organs-on-chips, that could improve early cancer detection and treatment. The review, led by the lab of Luiz Bertassoni, D.D.S., Ph.D., highlights OHSU’s role in advancing human-relevant cancer-model systems for earlier diagnosis. He says, “These new technologies give us a window into how cancer forms and progresses, which opens the door to understanding early cancer, paving the way for earlier diagnosis and even predict cancer initiation."

OHSU researchers review new technologies, such as organoids and organs-on-chips, that could improve early cancer detection and treatment. The review, led by the lab of Luiz Bertassoni, D.D.S., Ph.D., highlights OHSU’s role in advancing human-relevant cancer-model systems for earlier diagnosis. He says, “These new technologies give us a window into how cancer forms and progresses, which opens the door to understanding early cancer, paving the way for earlier diagnosis and even predict cancer initiation.”

OHSU researchers review new technologies, such as organoids and organs-on-chips, that could improve early cancer detection and treatment. The review, led by the lab of Luiz Bertassoni, D.D.S., Ph.D., highlights OHSU’s role in advancing human-relevant cancer-model systems for earlier diagnosis. He says, “These new technologies give us a window into how cancer forms and progresses, which opens the door to understanding early cancer, paving the way for earlier diagnosis and even predict cancer initiation."

Axios Portland writers walk the “4 T” loop — trail, tram, train and trolley — noting the trail goes through OHSU’s campus.

Coverage of a unique proof of concept to treat infertility by turning skin cells into oocytes capable of producing early human embryos continues. Paula Amato, M.D., says, “We know it works in nature, but we don’t fully understand how chromosomes pair and separate correctly. Now we’re trying to recapitulate that in vitro, and it’s incredibly challenging.”